Effect of Intravitreal Bevacizumab on Clinically Significant Macular Edema
Status:
Unknown status
Trial end date:
2007-02-01
Target enrollment:
Participant gender:
Summary
to compare the effect of intravitreal bevacizumab alone or in combination with triamcinolone
acetonide with laser photocoagulation on clinically significant macular edema (CSME)